Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)

Clinical trial NCT00191906 · COMPLETED

Trial details

NCT number: NCT00191906
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder Reading Disorder

Start date: 2005-04-01
Primary completion: 2007-12-01
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.